Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

Shanghai Public Health Clinical Center

Status: Unknown

Conditions: Coronavirus

Study type: Observational

Funder types: Other

Identifiers

NCT04292340

Anti-SARS-CoV-2

Details and patient eligibility

About

There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of COVID-19 pneumonia.

Enrollment: 15 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The participants were diagnosed as COVID-19;
• Participants received anti-SARS-CoV-2 inactivated convalescent plasma
• Written the informed consent.

Exclusion criteria

• Participants lacked detailed medical history